California Gov. Gavin Newsom (D) vetoed legislation Saturday to limit out-of-pocket insulin costs to $35 a month, leaving the largest state out of a growing number that have moved to limit rising prices in recent years.
Insurers lobbied against the measure (S.B. 90), arguing drug manufacturers are the real culprits behind the higher costs. But while the two industries have traded blame, the proposal to limit costs found bipartisan support.
Legislators passed the bill without a single vote against it, sending the measure last month to Newsom, who has railed against drug prices.
But Newsom argued in a ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.